X
    X
    X
    X

    Locke Lord Strengthens Pharma, Biotech and Life Sciences Capabilities With Addition of 3 Lawyers to IP Pharma Practice Group

    News

    Locke Lord has added three lawyers in the Firm's IP Pharmaceutical Practice Group, further strengthening the Firm's well-recognized capabilities in intellectual property issues for life sciences companies.

    Click here to read the complete PDF.

    Explore Additional Topics

    Disclaimer

    Please understand that your communications with Locke Lord LLP through this website do not constitute or create an attorney-client relationship with Locke Lord LLP. Any information you send to Locke Lord LLP through this website is on a non-confidential and non-privileged basis. Therefore, do not send or include any information in your email that you consider to be confidential or privileged.